Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (16) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) (-) Herse, Florian PD Dr. (1) (-) Popp, Oliver Dr. (3) (-) Röefzaad, Claudia (1) (-) Zimmermann, Karin Dr. (1) 2007 (1) 2008 (1) 2019 (1) 2021 (2) 2022 (1) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (90) Anchored Signalling (5) Animal Phenotyping (11) Bioinformatics and Omics Data Science (4) Biology of Malignant Lymphomas (2) Cardiac MRI (1) Cellular Neurosciences (4) Chromatin (dys)function in disease (1) Clinical Research Unit (3) Computational Regulatory Genomics (3) Electron Microscopy (1) Epigenetic Modifications in Neuroblastoma (2) Epigenetic Regulation and Chromatin Architecture (1) Flow Cytometry (1) From Cell States to Function (1) Genetics and Genomics of Cardiovascular Diseases (13) Genome Diversification & Integrity (3) Genome Engineering & Disease Models (5) Genomics (4) Host-microbiome factors in cardiovascular disease (3) Hypertension-caused End-Organ Damage (90) Hypertension-Mediated End-Organ Damage (90) Immune Regulation and Cancer (5) Integrative Vascular Biology (1) Intracellular Proteolysis (2) Mechanism-based Cancer Therapies (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (3) Molecular Biology of Peptide Hormones (14) Molecular Cardiovascular Research (3) Molecular Immunology and Gene Therapy (3) Molecular Oncology (1) Molecular Physiology of Somatic Sensation (1) Myology (1) Pluripotent Stem Cells (1) Proteome Dynamics (2) Proteomics (33) Proteomics and Metabolomics (1) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (2) Psychoneuroimmunology (3) Quantitative Developmental Biology (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (2) Synaptic Transmission and Plasticity (1) Systems Biology of Gene Regulatory Elements (6) Transgenics (5) Translational Bioinformatics (5) (-) Translational Oncology of Solid Tumors (6) 6 Results: Active Filter: Herse, Florian PD Dr.Popp, Oliver Dr.Röefzaad, ClaudiaZimmermann, Karin Dr.Translational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest February 23, 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke October 21, 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein May 01, 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig July 15, 2008 / Int J Cancer REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis C. Astrosini C. Roeefzaad Y.Y. Dai B.K. Dieckgraefe T. Joens W. Kemmner February 01, 2019 / Life Sci Alliance A C/EBPα-Wnt connection in gut homeostasis and carcinogenesis J. Heuberger U. Hill S. Förster K. Zimmermann V. Malchin A.A. Kühl U. Stein M. Vieth W. Birchmeier A. Leutz August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
February 23, 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke
October 21, 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein
May 01, 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig
July 15, 2008 / Int J Cancer REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis C. Astrosini C. Roeefzaad Y.Y. Dai B.K. Dieckgraefe T. Joens W. Kemmner
February 01, 2019 / Life Sci Alliance A C/EBPα-Wnt connection in gut homeostasis and carcinogenesis J. Heuberger U. Hill S. Förster K. Zimmermann V. Malchin A.A. Kühl U. Stein M. Vieth W. Birchmeier A. Leutz
August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein